Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 392 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07795398RecruitingPhase 4
Stopping aspirin in older adults with stable heart disease
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
CopenhagenAges 65 years+ - NCT07785765Enrolling by invitation
Exercise study for people recovering from SCAD
This study tests whether a supervised exercise program is safe and helpful for people who have had a spontaneous coronary artery dissection (SCAD), a tear in a heart artery. It may help improve your recovery and heart health.
OsloAges 18 years+ - NCT01258231Recruiting
Genetic test to predict risks after heart surgery
This study looks for genetic (DNA) clues that may help predict side effects or complications after heart surgery. If you join, your genome information may be used to understand who is at higher risk and why.
Boston, MassachusettsAges 20–90 - NCT07772570Recruiting
Studying blood markers in coronary artery disease
This study collects blood samples and images from patients with heart muscle damage or those undergoing coronary angiography. The goal is to find new biomarkers that could improve diagnosis and treatment of coronary artery disease.
OxfordAges 18–90 - NCT06521047Recruiting
Long-term follow-up for EXCELLENT trial participants
This study looks at the long-term health of people who took part in the EXCELLENT trial. If you finished that trial within the last 10 years, you may be able to join this study to help researchers understand how participants are doing over time.
Mulhouse, FranceAges 18 years+ - NCT06633809Recruiting
Treating minor stroke with large artery blockage
This study tests whether a specific treatment (likely endovascular therapy) helps people who have a minor stroke caused by a blockage in a large brain artery. If you are eligible, you may receive this treatment within 24 hours of your stroke to try to improve your recovery.
Hangzhou, ZhejiangAges 18 years+ - NCT07714746RecruitingPhase 3
Ivabradine for treating cardiogenic shock after heart attack
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
KarachiAges 18–75 - NCT07689591Recruiting
Non-invasive blood flow boost for heart attack patients
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
Elâzığ, ElaziğAges 18–80 - NCT07693816Recruiting
Finding stroke caused by small artery disease
This study looks at whether your stroke was caused by branch atheromatous disease (BAD), a type of small artery blockage. Knowing this may help choose the best treatment and prevention plan.
BeijingAges 18–80 - NCT07654634Enrolling by invitation
Precision blood thinning therapy study
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
Changsha, HunanAges 8 years+ - NCT04449523Recruiting
Check for hidden heart rhythm problems after silent brain strokes
This study looks at how often “silent” atrial fibrillation—an irregular heart rhythm that can be symptom-free—happens in people who have silent brain stroke spots on MRI. If it finds a link, it may help identify which patients might benefit from closer heart monitoring or prevention steps.
GrazAges 50 years+ - NCT07643610Recruiting
Heart Failure Crisis Registry Study
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Basel, Canton of Basel-CityAges 18 years+ - NCT07626060Recruiting
AI Tools for Chest Pain Risk Assessment
This study tests whether artificial intelligence (AI) programs can accurately calculate a chest pain risk score to help doctors decide who needs urgent heart tests. You'll be monitored for 30 days to see if the AI's predictions were correct.
Istanbul, IstanbulAges 18 years+ - NCT07619144Recruiting
Improving Heart Pump Outcomes Using Advanced Data Analysis
This study examines detailed data from patients who received an Impella 5.5 heart pump to treat cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood. Researchers use advanced computer analysis to understand what helps patients recover best.
ViennaAges 18 years+ - NCT07616622Enrolling by invitation
Recovery Methods for Upper Arm Weakness After Stroke
This study compares two physical therapy approaches—Roods (a sensory-based technique) and PNF (a stretching and strengthening method)—to help improve arm function in people recovering from their first stroke. Both methods aim to help you regain strength and control in your upper arm and hand.
Faisalābad, Punjab ProvinceAges 40–60 - NCT07617376RecruitingPhase 4
Flu shot before leaving hospital after heart problems
This study tests whether giving a flu vaccine to patients before they leave the hospital after a heart condition improves their health. The vaccine may help protect your heart and prevent serious flu complications while you recover.
WroclawAges 18 years+ - NCT07619885RecruitingPhase 1
Testing a New Blood Thinner Called CG-0255 in Healthy People
This study tests how a new blood-thinning medication (CG-0255) works in the body and compares it with Plavix, a common blood thinner. Researchers will measure how much of the drug enters your bloodstream and what effects it has on your blood clotting ability.
Miami, FloridaAges 18–55 - NCT07597291Recruiting
Understanding heart failure shock outcomes and treatments
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
Carnaxide, Lisbon DistrictAges 18 years+ - NCT07594314RecruitingPhase 2/Phase 3
Minocycline after stroke clot removal surgery
This trial tests whether minocycline, an antibiotic, can reduce brain damage when given after successful clot removal surgery for acute stroke. The goal is to see if this medication helps patients recover better.
Wuhan, HubeiAges 18 years+ - NCT07545512Recruiting
Finding heart attack risk markers in moderate heart weakness
This study helps doctors identify which heart attack survivors with moderate heart weakness are at highest risk of sudden cardiac death. Researchers will collect health information and heart imaging over 5 years to find early warning signs.
AmiensAges 18–80 - NCT07541014Recruiting
Home vs. Hospital Heart Rehab After Heart Attack
This study compares two ways to do cardiac rehabilitation (heart exercise and education programs) after a heart attack: one done at home via telehealth (video visits) and one at a clinic. The goal is to see which approach works better and is easier for patients to stick with.
New York, New YorkAges 18 years+ - NCT07530588Recruiting
Remote CT imaging for fast stroke treatment decisions
This study tests whether CT scans done remotely (by doctors at a distance) can help stroke patients receive clot-busting treatment faster. Stroke treatment works best when given quickly, and this approach aims to speed up diagnosis in areas far from major hospitals.
SandnessjøenAges 18 years+ - NCT06753591Recruiting
Premature heart attack registry in Serbia
This trial is creating a registry of young adults (45 and under) who have had a heart attack. It will collect information to help doctors better understand and treat early heart attacks.
BelgradeAges 18–45 - NCT07521930Recruiting
Brain implant to restore communication and movement control
This trial tests a surgically implanted brain device designed to help people with severe paralysis or movement disorders regain the ability to communicate and control their limbs. The device reads signals from your brain and translates them into commands that could help you interact with computers or assistive technology.
Baltimore, MarylandAges 18–80
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 392 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.